1. Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20+ B-cell lymphoma. (March 2015) Authors: Reichwagen, Annegret; Ziepert, Marita; Kreuz, Markus; Gödtel-Armbrust, Ute; Rixecker, Tanja; Poeschel, Viola; Reza Toliat, Mohammad; Nürnberg, Peter; Tzvetkov, Mladen; Deng, Shiwei; Trümper, Lorenz; Hasenfuss, Gerd; Pfreundschuh, Michael; Wojnowski, Leszek Journal: Pharmacogenomics Issue: Volume 16:Number 4(2015) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial. Issue 12 (1st December 2022) Authors: Braulke, Friederike; Zettl, Florian; Ziepert, Marita; Viardot, Andreas; Kahl, Christoph; Prange-Krex, Gabriele; Korfel, Agnieszka; Dreyling, Martin; Bott, Alexander; Wedding, Ulrich; Reichert, Dietmar; de Wit, Maike; Hartmann, Frank; Poeschel, Viola; Schmitz, Norbert; Witzens-Harig, Mathias; Klap... Journal: HemaSphere Issue: Volume 6:Issue 12(2022) Page Start: e808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Issue 10216 (21st December 2019) Authors: Poeschel, Viola; Held, Gerhard; Ziepert, Marita; Witzens-Harig, Mathias; Holte, Harald; Thurner, Lorenz; Borchmann, Peter; Viardot, Andreas; Soekler, Martin; Keller, Ulrich; Schmidt, Christian; Truemper, Lorenz; Mahlberg, Rolf; Marks, Reinhard; Hoeffkes, Heinz-Gert; Metzner, Bernd; Dierlamm, Judi... Journal: Lancet Issue: Volume 394:Issue 10216(2019) Page Start: 2271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. KIR2DS1–HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials. Issue 2 (February 2022) Authors: Kaddu-Mulindwa, Dominic; Altmann, Bettina; Robrecht, Sandra; Ziepert, Marita; Regitz, Evi; Tausch, Eugen; Held, Gerhard; Poeschel, Viola; Lesan, Vadim; Bittenbring, Joerg Thomas; Thurner, Lorenz; Pfreundschuh, Michael; Christofyllakis, Konstantinos; Truemper, Lorenz; Loeffler, Markus; Schmitz, No... Journal: Lancet Issue: Volume 9:Issue 2(2022) Page Start: e133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group. Issue 1 (13th July 2020) Authors: Hohloch, Karin; Ziepert, Marita; Truemper, Lorenz; Buske, Christian; Held, Gerhard; Poeschel, Viola; Chapuy, Bjoern; Altmann, Bettina Journal: EJHaem Issue: Volume 1:Issue 1(2020) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group. Issue 1 (13th July 2020) Authors: Hohloch, Karin; Ziepert, Marita; Truemper, Lorenz; Buske, Christian; Held, Gerhard; Poeschel, Viola; Chapuy, Bjoern; Altmann, Bettina Journal: EJHaem Issue: Volume 1:Issue 1(2020) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group. Issue 1 (13th July 2020) Authors: Hohloch, Karin; Ziepert, Marita; Truemper, Lorenz; Buske, Christian; Held, Gerhard; Poeschel, Viola; Chapuy, Bjoern; Altmann, Bettina Journal: EJHaem Issue: Volume 1:Issue 1(2020) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma. Issue 2 (10th February 2022) Authors: Houot, Roch; Poeschel, Viola; Altmann, Bettina; Angel, Stephanie; Thurner, Lorenz; Illmer, Thomas; Andre, Marc; Dreyling, Martin; Maisonneuve, Hervé; Tilly, Hervé; Mayer, Stephanie; Casasnovas, Olivier; Le Gouill, Steven; Offner, Fritz; Cartron, Guillaume; Kerkhoff, Andrea; Weber, Thomas; Hoffman... Journal: HemaSphere Issue: Volume 6:Issue 2(2022) Page Start: e672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma. Issue 5 (18th March 2021) Authors: Maurer, Matthew J.; Jakobsen, Lasse H.; Mwangi, Raphael; Schmitz, Norbert; Farooq, Umar; Flowers, Cristopher R.; de Nully Brown, Peter; Thompson, Carrie A.; Frederiksen, Henrik; Cunningham, David; Jørgensen, Judit; Poeschel, Viola; Nowakowski, Grzegorz; Seymour, John F.; Merli, Francesco; Haioun,... Journal: American journal of hematology Issue: Volume 96:Issue 5(2021) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial. Issue 2 (28th January 2022) Authors: Kaddu-Mulindwa, Dominic; Lesan, Vadim; Berdel, Christian; Stilgenbauer, Stephan; Bewarder, Moritz; Thurner, Lorenz; Witzens-Harig, Mathias; Viardot, Andreas; Soekler, Martin; Keller, Ulrich; Truemper, Lorenz; Christofyllakis, Konstantinos; Fleser, Octavian; Bittenbring, Joerg Thomas; Poeschel, Vi... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 2(2022) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗